Physician profile
Jody Murray
NPI 1043477524
$6,716.18
in general payments reported to CMS, 2019-2025
20 companies · $1,399 in 2025
The $1,399 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,016 · 2022: $1,604 · 2023: $280 · 2024: $416 · 2025: $1,399.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,046 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,045.66 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Masimo Corporation | $2,382.34 | 2021 | |
| Boston Scientific Corporation | $961.53 | 2021-2024 | Watchman Access System, Watchman Flx |
| Abbott Laboratories | $959.91 | 2021-2025 | Navitor, Jot Dx, Thoratec Heartmate 3 Lvas Implant Kit |
| Edwards Lifesciences Corporation | $671.39 | 2025 | Sapien 3 Ultra Resilia, Evoque |
| Astrazeneca Pharmaceuticals LP | $287.30 | 2022-2024 | Wainua |
| Medtronic, INC. | $265.16 | 2025 | Symplicity G3, Corevalve Evolut R |
| Pfizer INC. | $226.53 | 2021-2025 | |
| Amgen INC. | $192.90 | 2021-2024 | Repatha |
| Novartis Pharmaceuticals Corporation | $154.21 | 2021-2024 | |
| Novo Nordisk INC | $124.80 | 2022 | |
| Heartflow, INC. | $100.54 | 2025 | |
| Kestra Medical Technology Services, INC. | $91.30 | 2025 | Assure Wcd |
| E.R. Squibb & Sons, L.L.C. | $83.07 | 2022-2025 | Camzyos |
| Shockwave Medical, INC | $50.00 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.67 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Actelion Pharmaceuticals US, INC. | $34.00 | 2024 | Opsumit, Uptravi |
| Janssen Biotech, INC. | $26.04 | 2022 | |
| Cleerly, INC. | $25.00 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Bayer Healthcare Pharmaceuticals INC. | $22.41 | 2025 | |
| Alexion Pharmaceuticals, INC. | $18.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.